The SILK Collaborative: A Multidisciplinary Approach to Serious Illness Communication for Patients with Liver Failure and AKI
- PMID: 38323851
- PMCID: PMC11000718
- DOI: 10.34067/KID.0000000000000382
The SILK Collaborative: A Multidisciplinary Approach to Serious Illness Communication for Patients with Liver Failure and AKI
Conflict of interest statement
A.S. Allegretti reports the following: Consultancy: Mallinckrodt Pharmaceuticals and Ocelot Bio; and Research Funding: Mallinckrodt Pharmaceuticals. All remaining authors have nothing to disclose.
Figures
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
